Skip to main content

Biomedical, Clinical & Life Sciences

Rita Allen Foundation Scholars Program

Internal Competition Under Peer Review // Limit: 1 // Tickets Available: 1

Limiting Language
One nominated candidate per eligible institution is accepted per year

Program Overview
The Rita Allen Foundation Scholars program funds basic biomedical research in the fields of cancer, immunology, and neuroscience, as well as pain, through the Rita Allen Foundation Award in Pain. The Rita Allen Foundation Scholars program has supported more than 200 scientists since 1976. The program embraces innovative research with above-average risk and groundbreaking possibilities. Scholars have gone on to win the Nobel Prize in Physiology or Medicine, the National Medal of Science, the Wolf Prize in Medicine and the Breakthrough Prize in Life Sciences.

Full sponsor guidelines are linked here. 

Award Amount
Scholars can receive up to $110,000 per year for a maximum of five years. Recipients of the Award in Pain can be granted $50,000 per year for up to three years.

Eligibility
To be eligible for a Rita Allen Foundation Scholars Award, candidates must either apply through the Scholars Award in Pain or be nominated by an eligible institution and have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in research in one of the relevant fields (cancer, immunology, neuroscience. or pain). United States citizenship is not a requirement; however, awardees must be legally employed at the time of application at a U.S. degree-granting or research institution that is an invited participant in the Rita Allen Foundation Scholars Program. Awards are made to the 501(c)(3) organization; awards are not made to an individual. Scholars must perform research at a non-profit institution in the U.S. during the entire period of Rita Allen Foundation support.

Institutions should consider the following when considering whom to nominate for the Rita Allen Foundation Scholars program: 

  • Candidates should be independent investigators in the early stages of their careers and research. 
  • The caliber of early-stage investigators suggests nominees would be appointed to tenure-track positions at their respective institutions. 
  • It is preferable that candidates be in the first three years of their tenure track. (This is taken into consideration in the rating of applications by the Scientific Advisory Committee.) 
  • A senior postdoc should not be a candidate; wait until s/he is in a tenure-track position, as described. 
  • Associate professors should not be candidates. 
  • Candidates must have received committed startup funds from their respective institutions. 
  • Candidates must have lab space from their institutions. 

Rita Allen Foundation Scholars may not accept an award from the Beckman Young Investigator Program, Pew Scholars Program in the Biomedical Sciences, Searle Scholars Program, or Vallee Scholars Program that would take effect beginning in year one of the RAF award. Rita Allen Scholars may apply for awards from these organizations that would take effect beginning in year two of the RAF award. Other sources of funding also may influence selection. 

Funding Type
External Deadline
9/3/2026 (LOI; Anticipated)
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Medical Student Education Program (MSE)

Request Ticket // Limit: 1 (COM-T) // Tickets Available: 1 

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.


Purpose
The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in states ranked in the top quartile for projected primary care provider shortages. to expand or enhance education for medical students preparing to become physicians. This expansion can include funding for direct student supports which help students be successful in medical school, as well as for infrastructure development, maintenance, equipment, and minor renovations or alterations. The program is designed to prepare and encourage medical students to choose residencies and careers in primary care and serve Tribal, rural and other areas with primary care provider shortages in those states after they complete their residency.

  • Increase the number of primary care physicians practicing in states with a projected primary care physician shortage, particularly in rural Tribal and other areas with primary care provider shortages.
Funding Type
External Deadline
9/1/2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs. Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts

The RCC will lead, manage, and harmonize efforts for the Consortium including 1) providing management and administrative support; 2) providing leadership and expertise on statistical design and analysis, 3) providing research coordination with a central laboratory, 4) harmonizing data collection methods and use of common data elements, 5) developing the database; 6) conducting data management and data analyses for Consortium studies; and 7) fostering research collaborations. This NOFO uses a cooperative agreement mechanism (U24) and runs in parallel with a companion NOFO (RFA-DK-27-121).

Full sponsor guidelines are linked here. 
 

Funding Type
External Deadline
10/9/2026
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.


Purpose
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs.  Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. 

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
10/9/2026
Internal Deadline
Internal Time
5:00PM
Solicitation Type

FY 2026 Susan Harwood Training Grant Program (Targeted Topic Training and Training and Educational Materials Development Grants)

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
If an organization submits multiple applications for this or other Harwood funding opportunities, OSHA will review the last viable application package submitted.

Grant Types

  • Targeted Topic Training 
    Supports educational programs that identify and prevent workplace hazards and requires applicants to conduct training on OSHA-designated workplace safety and health hazards
  • Training and Educational Materials Development
    Supports the.development of quality, classroom-ready training and educational materials that identify and prevent workplace hazards.

     

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

Purpose
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
9/24/2026
Solicitation Type

Small Health Care Provider Quality Improvement Program

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Summary
The Small Health Care Provider Quality Improvement Program supports the planning and implementation of quality improvement activities for rural primary care providers or providers of health care services, such as critical access hospitals (CAH), rural health clinics (RHC), or a network of rural health providers, to increase access to high quality health care services and improve health.

Funding Type
External Deadline
8/6/2026

Scholarships for Disadvantaged Students (SDS)

One per health profession degree program (see eligibility below)

J. Young (College of Nursing) - degree programs include bachelor's degree nursing students (BSN), master's entry program to nursing (MEPN), and doctor of nursing practice (DNP). 

M. Alt (College of Science), Speech, Language, and Hearing Sciences (SLHS) - Allied health, Graduate Degree in Speech pathology.

Limiting Language
You may submit more than one application under the same Unique Entity Identifier (UEI) if each proposes a distinct project. We will only review your last validated application for each distinct project before the deadline. 

You may not submit more than one application per health professions degree program. If you submit more than one application, we will only accept the last on-time submission. 

While multiple applications from an institution are allowed, only a maximum of three per institution may be funded. Collaborative proposals are not allowed.

Eligible Health Profession Degree Programs
Eligible health professions schools include the following: 

  1. Medicine (Doctor of allopathic medicine, Doctor of osteopathic medicine); 
  2. Dentistry (Doctor of dentistry); 
  3. Other health disciplines (Doctor of veterinary medicine, Doctor of optometry, Doctor of podiatry medicine, Doctor of pharmacy, Doctor of chiropractic medicine); 
  4. Behavioral and mental health (Graduate degree in clinical psychology; Graduate degree in clinical social work; Graduate degree in gerontological counseling; Graduate degree in marriage and family therapy; Graduate degree in mental health counseling; Graduate degree in rehabilitation counseling); 
  5. Public health (Graduate degree in health administration; Graduate degree in public health); 
  6. Allied health (Bachelor's and graduate degrees in dietetics; Graduate degree in audiology; Graduate degree in occupational therapy; Graduate degree in physical therapy; Graduate degree in speech pathology; Bachelor's and graduate degrees in dental hygiene; Bachelor's and graduate degrees in medical laboratory technology, Bachelor's degree in radiologic technology); 
  7. Nursing (Associate, bachelor's, and graduate degrees in nursing (pre-nursing is not eligible)); 
  8. Midwifery (Certified nursing and non-nursing graduate degrees in midwifery (pre-nursing or pre-midwifery is not eligible));
  9. Physician Assistant (Graduate degree in physician assistant studies).

Summary
The Scholarships for Disadvantaged Students (SDS) program increases the health professionsand nursing workforce by providing awards to eligible health professions schools for use in awarding scholarships to students from disadvantaged backgrounds who have a financial need.

Funding Type
External Deadline
7/28/2026

Great Health for America

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Under this NOFO, you may submit only one application for one program site (Lake County, Indiana; Sandusky and Toledo metro area, Ohio; Brownsville, Texas; Petersburg, Virginia) under your organization’s Unique Entity Identifier (UEI).

Summary
In collaboration with U.S. Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), state and federally funded programs, you will implement a project focused on reducing chronic disease rates within a defined geographic area within four communities: Lake County, Indiana; Sandusky and Toledo metro area, Ohio; Brownsville, Texas; Petersburg, Virginia. The goal is to demonstrate how individual and system- level interventions can encourage healthier habits and choices that can reduce the burden of chronic disease in children. When these lifestyle and community changes are maintained over time, reductions in the burden of chronic diseases among adults in the United States may eventually result. Findings from these demonstration programs will inform the potential replication of successful interventions in additional communities. 

Additionally, HHS will use findings from this demonstration project to inform future approaches to funding and measuring effects of novel efforts to improve health for individuals and communities.

NIH Director's Early Independence Award (DP5 Clinical Trial Optional)

Request Ticket // Limit: 2 // Tickets Available: 2

Limiting Language 
Only two applications per institution (identified by Unique Entity Identifier (UEI) number or NIH IPF number) are allowed.


Program Description
Full sponsor guidelines are linked here.

The NIH Director's Early Independence Award helps talented new researchers begin their own independent research program soon after finishing their doctoral degree or clinical training, without first doing postdoctoral training.The award accepts applications on any topic fitting the NIH mission. It is part of the NIH Common Fund's High-Risk, High-Reward Research program.

Eligible Individuals (Program Director/Principal Investigator)
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. 

Requirements

  • One PD/PI only: Applications can have only one PD/PI. Multiple PD/PIs are not allowed. Only the PD/PI may be listed as Senior/Key Personnel and submit a biosketch.
  • Citizenship: U.S. citizenship is not required. If the PD/PI is not a U.S. citizen, the institution must ensure the visa permit allows them to do the proposed research in the U.S. for the full project period.
  • Degree or clinical training dates: The PD/PI must complete their terminal doctoral degree or post-graduate clinical training between May 1, 2025, and September 30, 2027.
    • The date shown on the official transcript is considered the date the degree was completed.
    • Clinical training includes residency and fellowship.
    • At the time of award, either:
      • The PD/PI must have an eligible doctoral degree from an accredited U.S. or foreign institution, oR
      • An authorized official must confirm all degree requirements are complete and the degree will be awarded before September 30, 2027.
  • Post-doctoral experience: The PD/PI must not have more than 12 months of postdoctoral training after an earlier, non-terminal doctoral degree. This applies only to individuals with multiple doctoral degrees.
  • Effort required:
    • Years 1-2: At least 9.6 person-months per year (80% effort) on the award project
    • Years 3-5:  At least 9.6 person-months per year (80% effort) on independent research overall, including the award project and any other independent research led by the PD/PI.
  • Non-independence required: At the time of application, the PD/PI must still be non-independent. All the following must apply:
    • Research direction requires mentor approval
    • Research is mainly supported through another investigator's funding (mentored fellowships, such as an NIH F31/F32 or NSF Graduate Research Fellowship, do not make an applicant ineligible)
    • No institutionally assigned research space
    • Cannot apply for an NIH R01 without a special institutional waiver or exception

The PD/PI may become independent before the award starts and still remain eligible.

  • Independent position required: The PD/PI must have a guaranteed, pending independent research position and be able to begin independent research by the project start date.
    • The position does not have to be permanent or tenure-track.
    • The position may depend on receiving this award.
    • The institution must provide substantial support, as described in the application.
    • Moving to a new institution may be advantageous but is not required.
  • Career awards: ThePD/PI may apply for both a K award and DP5 simultaneously, but the projects must not overlap scientifically. A PD/PI cannot hold both simultaneously; if awarded the DP5, the K award must be relinquished.
  • Site visit: NIH will conduct a site visit near the end of the first year to assess progress and confirm institutional support and independence. If support is insufficient, NIH may take corrective action, including reducing or terminating funding.
Funding Type
External Deadline
9/10/2026
Internal Deadline
Solicitation Type